The commitments of $3.5 million from the ALS Association (including $1 million from the association's Greater New York Chapter) and $2.5 million from the Tow Foundation follow earlier commitments from the two organizations in the wake of the ALS Ice Bucket Challenge, when the ALS Association matched a $2.5 million gift from the Tow Foundation. To date, those grants have helped fund the sequencing and analysis of thousands of ALS genomic samples and the pairing of that information with patients' clinical history, leading to a better understanding of ALS disease pathways and new ALS gene discoveries.
The new funding from the two organizations will be used to further the work of CGND as it leverages the expertise of NYGC scientists and partners to translate its genomic research into innovative advances in clinical care and accelerate the development of new treatments.
"The ALS Association is proud to continue our support for the critical work the NYGC CGND is doing to reveal genomic patterns and pathways that help us better understand the complexities of ALS," said ALS Association president and CEO Calaneet Balas. "NYGC CGND has helped create a flourishing ALS big data community focused on innovation and open data sharing. We look forward to seeing the many new discoveries that it will continue to generate."